Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Identification of novel compounds against three targets of SARS CoV-2 coronavirus by combined virtual screening and supervised machine learning
Onat Kadioglu, Mohamed E.M. Saeed, Henry Johannes Greten, et al.
(2020)
Closed Access | Times Cited: 51

Showing 1-25 of 51 citing articles:

Machine and Deep Learning towards COVID-19 Diagnosis and Treatment: Survey, Challenges, and Future Directions
Tarik Alafif, Abdul Muneeim Tehame, Saleh Bajaba, et al.
International Journal of Environmental Research and Public Health (2021) Vol. 18, Iss. 3, pp. 1117-1117
Open Access | Times Cited: 125
Artificial Intelligence for COVID-19: Rapid Review
Jiayang Chen, Kay Choong See
Journal of Medical Internet Research (2020) Vol. 22, Iss. 10, pp. e21476-e21476
Open Access | Times Cited: 126
A multi-pronged approach targeting SARS-CoV-2 proteins using ultra-large virtual screening
Christoph Gorgulla, Krishna Mohan Das, Kendra E. Leigh, et al.
iScience (2021) Vol. 24, Iss. 2, pp. 102021-102021
Open Access | Times Cited: 84
Machine learning research towards combating COVID-19: Virus detection, spread prevention, and medical assistance
Osama Shahid, Mohammad Nasajpour, Seyedamin Pouriyeh, et al.
Journal of Biomedical Informatics (2021) Vol. 117, pp. 103751-103751
Open Access | Times Cited: 66
The natural way forward: Molecular dynamics simulation analysis of phytochemicals from Indian medicinal plants as potential inhibitors of SARS‐CoV‐2 targets
Pratap Parida, Dipak Paul, Debamitra Chakravorty
Phytotherapy Research (2020) Vol. 34, Iss. 12, pp. 3420-3433
Open Access | Times Cited: 66
Virtual screening of anti-HIV1 compounds against SARS-CoV-2: machine learning modeling, chemoinformatics and molecular dynamics simulation based analysis
Mahesha Nand, Priyanka Maiti, Tushar Joshi, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 49
Contribution of machine learning approaches in response to SARS-CoV-2 infection
Mohammad Sadeq Mottaqi, Fatemeh Mohammadipanah, Hedieh Sajedi
Informatics in Medicine Unlocked (2021) Vol. 23, pp. 100526-100526
Open Access | Times Cited: 45
A comprehensive review on potential therapeutics interventions for COVID-19
Heerak Chugh, Amardeep Awasthi, Yashi Agarwal, et al.
European Journal of Pharmacology (2020) Vol. 890, pp. 173741-173741
Open Access | Times Cited: 41
Rutin: A Potential Antiviral for Repurposing as a SARS-CoV-2 Main Protease (Mpro) Inhibitor
Pawan K. Agrawal, Chandan Agrawal, Gerald Blunden
Natural Product Communications (2021) Vol. 16, Iss. 4
Open Access | Times Cited: 31
Main protease inhibitors and drug surface hotspots for the treatment of COVID-19: A drug repurposing and molecular docking approach
Mahmudul Hasan, Md. Sorwer Alam Parvez, Kazi Faizul Azim, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 140, pp. 111742-111742
Open Access | Times Cited: 23
Brazilian essential oils as source for the discovery of new anti-COVID-19 drug: a review guided by in silico study
Tatiane Roquete Amparo, Janaína Brandão Seibert, Benila Maria Silveira, et al.
Phytochemistry Reviews (2021) Vol. 20, Iss. 5, pp. 1013-1032
Open Access | Times Cited: 23
Amiodarone in the COVID-19 Era: Treatment for Symptomatic Patients Only, or Drug to Prevent Infection?
Fabián Sanchis‐Gomar, Carl J. Lavie, Daniel P. Morin, et al.
American Journal of Cardiovascular Drugs (2020) Vol. 20, Iss. 5, pp. 413-418
Open Access | Times Cited: 26
Dual inhibition of SARS-CoV-2 spike and main protease through a repurposed drug, rutin
Anchala Kumari, Vikrant Singh Rajput, Priya Nagpal, et al.
Journal of Biomolecular Structure and Dynamics (2020) Vol. 40, Iss. 11, pp. 4987-4999
Open Access | Times Cited: 25
Potential Inhibitors of Lumpy Skin Disease’s Viral Protein (DNA Polymerase): A Combination of Bioinformatics Approaches
S. H. Zia, Md-Mehedi Sumon, Md-Ashikur Ashik, et al.
(2024)
Open Access | Times Cited: 2
A Revisit to the Research Updates of Drugs, Vaccines, and Bioinformatics Approaches in Combating COVID-19 Pandemic
Tofael Ahmed Sumon, Md. Ashraf Hussain, Md Tawheed Hasan, et al.
Frontiers in Molecular Biosciences (2021) Vol. 7
Open Access | Times Cited: 18
Pharmaceutical Targeting the Envelope Protein of SARS-CoV-2: the Screening for Inhibitors in Approved Drugs
Anatoly Chernyshev
(2020)
Open Access | Times Cited: 20
Phosphate Derivatives of 3-Carboxyacylbetulin: SynThesis, In Vitro Anti-HIV and Molecular Docking Study
Krzysztof Marciniec, Elwira Chrobak, Aleksandra Dąbrowska, et al.
Biomolecules (2020) Vol. 10, Iss. 8, pp. 1148-1148
Open Access | Times Cited: 19
Computer-Aided Analysis of Multiple SARS-CoV-2 Therapeutic Targets: Identification of Potent Molecules from African Medicinal Plants
Franklyn Nonso Iheagwam, Solomon O. Rotimi
Scientifica (2020) Vol. 2020, pp. 1-25
Open Access | Times Cited: 18
The Novel Drug Discovery to Combat COVID-19 by Repressing Important Virus Proteins Involved in Pathogenesis Using Medicinal Herbal Compounds
Samira Mahmoudi, Negar Balmeh, Niloofar Mohammadi, et al.
Avicenna Journal of Medical Biotechnology (2021)
Open Access | Times Cited: 16
Molecular basis of COVID-19 pathogenesis
Fedor N. Novikov, Viktor S. Stroylov, Igor V. Svitanko, et al.
Russian Chemical Reviews (2020) Vol. 89, Iss. 8, pp. 858-878
Closed Access | Times Cited: 17
New Insights Into Potential Benefits of Bioactive Compounds of Bee Products on COVID-19: A Review and Assessment of Recent Research
Ehab Kotb Elmahallawy, Yasser Mohamed, Walied Abdo, et al.
Frontiers in Molecular Biosciences (2021) Vol. 7
Open Access | Times Cited: 14
Machine and Deep Learning Towards COVID-19 Diagnosis and Treatment: Survey, Challenges, and Future Directions
Tarik Alafif
(2020)
Open Access | Times Cited: 15
A Bioinformatics Study of Structural Perturbation of 3CL-Protease and the HR2-Domain of SARS-CoV-2 Induced by Synergistic Interaction with Ivermectins
Lenin González-Paz, Carla Lossada, Luis Moncayo, et al.
Biointerface Research in Applied Chemistry (2020) Vol. 11, Iss. 2, pp. 9813-9826
Open Access | Times Cited: 12
Nature to Nurture- Identifying Phytochemicals from Indian Medicinal Plants as Prophylactic Medicine by Rational Screening to Be Potent Against Multiple Drug Targets of SARS-CoV-2
Pratap Parida, Dipak Paul, Debamitra Chakravorty
(2020)
Closed Access | Times Cited: 12
Pharmaceutical Targeting the Envelope Protein of SARS-CoV-2: the Screening for Inhibitors in Approved Drugs
Anatoly Chernyshev
(2020)
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top